Galecto (GLTO) Competitors $2.83 -0.04 (-1.39%) Closing price 04:00 PM EasternExtended Trading$2.77 -0.06 (-2.08%) As of 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GLTO vs. MTEX, EDSA, ETHZ, LPCN, IBIO, ADAP, MTVA, BLRX, COCP, and ATHAShould you be buying Galecto stock or one of its competitors? The main competitors of Galecto include Mannatech (MTEX), Edesa Biotech (EDSA), Flag Ship Acquisition (ETHZ), Lipocine (LPCN), iBio (IBIO), Adaptimmune Therapeutics (ADAP), MetaVia (MTVA), BioLineRx (BLRX), Cocrystal Pharma (COCP), and Athira Pharma (ATHA). These companies are all part of the "pharmaceutical products" industry. Galecto vs. Its Competitors Mannatech Edesa Biotech Flag Ship Acquisition Lipocine iBio Adaptimmune Therapeutics MetaVia BioLineRx Cocrystal Pharma Athira Pharma Mannatech (NASDAQ:MTEX) and Galecto (NASDAQ:GLTO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership. Does the media favor MTEX or GLTO? In the previous week, Mannatech had 1 more articles in the media than Galecto. MarketBeat recorded 4 mentions for Mannatech and 3 mentions for Galecto. Galecto's average media sentiment score of 0.96 beat Mannatech's score of 0.94 indicating that Galecto is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mannatech 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Galecto 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, MTEX or GLTO? Mannatech has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500. Comparatively, Galecto has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500. Do analysts recommend MTEX or GLTO? Galecto has a consensus price target of $10.00, suggesting a potential upside of 253.36%. Given Galecto's stronger consensus rating and higher probable upside, analysts plainly believe Galecto is more favorable than Mannatech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mannatech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Galecto 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings and valuation, MTEX or GLTO? Mannatech has higher revenue and earnings than Galecto. Mannatech is trading at a lower price-to-earnings ratio than Galecto, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMannatech$117.87M0.13$2.49M-$2.04-4.04GalectoN/AN/A-$21.44M-$13.13-0.22 Do institutionals & insiders hold more shares of MTEX or GLTO? 13.0% of Mannatech shares are owned by institutional investors. Comparatively, 14.2% of Galecto shares are owned by institutional investors. 41.5% of Mannatech shares are owned by insiders. Comparatively, 10.8% of Galecto shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is MTEX or GLTO more profitable? Galecto has a net margin of 0.00% compared to Mannatech's net margin of -3.46%. Mannatech's return on equity of -48.60% beat Galecto's return on equity.Company Net Margins Return on Equity Return on Assets Mannatech-3.46% -48.60% -10.70% Galecto N/A -115.70%-95.42% SummaryGalecto beats Mannatech on 8 of the 15 factors compared between the two stocks. Get Galecto News Delivered to You Automatically Sign up to receive the latest news and ratings for GLTO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GLTO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GLTO vs. The Competition Export to ExcelMetricGalectoMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.74M$3.10B$5.74B$10.24BDividend YieldN/A2.32%5.69%4.59%P/E Ratio-0.2221.3874.9326.41Price / SalesN/A244.04457.2789.16Price / CashN/A44.4425.8129.91Price / Book0.269.6413.256.28Net Income-$21.44M-$53.20M$3.29B$270.38M7 Day Performance-8.41%0.44%0.47%2.70%1 Month Performance-16.89%4.26%4.60%5.99%1 Year Performance-78.11%9.43%73.42%25.94% Galecto Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GLTOGalecto3.432 of 5 stars$2.83-1.4%$10.00+253.4%-77.8%$3.74MN/A-0.2240Positive NewsShort Interest ↓Gap DownMTEXMannatech0.9775 of 5 stars$8.87-7.5%N/A+7.2%$16.84M$117.87M-4.35250Positive NewsShort Interest ↓Gap DownEDSAEdesa Biotech1.4499 of 5 stars$2.38+2.4%$5.00+110.5%-43.9%$16.71MN/A-1.8020Gap UpETHZFlag Ship AcquisitionN/A$2.72-3.2%N/AN/A$16.43MN/A-0.187News CoverageGap UpLPCNLipocine3.4598 of 5 stars$2.96+1.8%$9.00+204.0%-35.4%$16.09M$11.20M-3.4110Positive NewsIBIOiBio1.6936 of 5 stars$0.80-2.4%$5.00+526.6%-51.6%$15.78M$375K0.00100Short Interest ↑ADAPAdaptimmune Therapeutics2.1117 of 5 stars$0.06-2.2%$1.35+2,246.6%-95.0%$15.27M$178.03M-0.09490News CoverageShort Interest ↑Gap UpMTVAMetaVia2.4196 of 5 stars$0.63-0.6%$7.50+1,090.3%N/A$15.25MN/A0.008Trading HaltedBLRXBioLineRx3.4803 of 5 stars$3.67-3.2%$26.00+608.4%-83.7%$15.17M$28.94M-0.4040Positive NewsCOCPCocrystal Pharma2.2651 of 5 stars$1.46-3.0%$6.00+312.4%-5.4%$15.08MN/A-1.1910News CoverageShort Interest ↑Gap DownATHAAthira Pharma2.8608 of 5 stars$0.38-2.7%$0.50+32.3%-31.8%$14.91MN/A-0.2440 Related Companies and Tools Related Companies Mannatech Competitors Edesa Biotech Competitors Flag Ship Acquisition Competitors Lipocine Competitors iBio Competitors Adaptimmune Therapeutics Competitors MetaVia Competitors BioLineRx Competitors Cocrystal Pharma Competitors Athira Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GLTO) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galecto, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galecto With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GLTO Stock Alerts